Ultra‐long‐acting insulin degludec has a flat and stable glucose‐lowering effect in type 2 diabetes-Reference-Cited by-同舟云学术

Ultra‐long‐acting insulin degludec has a flat and stable glucose‐lowering effect in type 2 diabetes

Published:2012-07-10 Issue:10 Volume:14 Page:944-950
ISSN:1462-8902
Container-title:Diabetes, Obesity and Metabolism
language:en
Short-container-title:Diabetes Obes Metab

Author:

Heise T.¹,Nosek L.¹,Bøttcher S. G.²,Hastrup H.²,Haahr H.²

Affiliation:

1. Profil Institute for Metabolic Research Neuss Germany

2. Novo Nordisk A/S Søborg Denmark

Publisher

Wiley

Subject

Endocrinology,Endocrinology, Diabetes and Metabolism,Internal Medicine

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1463-1326.2012.01638.x

Reference21 articles.

1. Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies

2. Insulin degludec is a new generation ultra‐long acting basal insulin with a unique mechanism of protraction based on multi‐hexamer formation;Jonassen I;Diabetes,2010

3. Multi‐hexamer formation is the underlying basis for the ultra‐long glucose‐lowering effect of insulin degludec;Kurtzhals P;Diabetologia,2011

4. Pharmacokinetics and pharmacodynamics of subcutaneous injection of long-acting human insulin analog glargine, NPH insulin, and ultralente human insulin and continuous subcutaneous infusion of insulin lispro.

Cited by 263 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Observation of the Clinical Efficacy and Safety of degludec/insulin aspart Combined with Metformin in Type 2 Diabetes Patients with Poor Blood Sugar Control.;2024-01-29

2. Efficacy and safety of insulin glargine 300 units/mL vs insulin degludec in patients with type 1 and type 2 diabetes: a systematic review and meta-analysis;Frontiers in Endocrinology;2024-01-19

3. The role of basal insulins in the treatment of people with type 2 diabetes and chronic kidney disease: A narrative review;Diabetes, Obesity and Metabolism;2024-01-15

4. Use of Second-Generation Basal Insulin Gla-300 in Special Populations: A Narrative Mini-Review;Current Diabetes Reviews;2023-11

5. Pharmacokinetic and pharmacodynamic properties of once‐weekly insulin icodec in individuals with type 2 diabetes;Diabetes, Obesity and Metabolism;2023-09-11